790 related articles for article (PubMed ID: 10872884)
41. Enhanced CD4
Dwyer AJ; Ritz JM; Mitchell JS; Martinov T; Alkhatib M; Silva N; Tucker CG; Fife BT
Sci Rep; 2021 Aug; 11(1):17142. PubMed ID: 34433860
[TBL] [Abstract][Full Text] [Related]
42. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct.
Young EF; Hess PR; Arnold LW; Tisch R; Frelinger JA
Autoimmunity; 2009; 42(8):678-91. PubMed ID: 19886740
[TBL] [Abstract][Full Text] [Related]
43. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats.
Weringer EJ; Like AA
Am J Pathol; 1988 Aug; 132(2):292-303. PubMed ID: 3135758
[TBL] [Abstract][Full Text] [Related]
44. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
45. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
46. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
[TBL] [Abstract][Full Text] [Related]
47. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
Saï P; Senecat O; Martignat L; Gouin E
Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
[TBL] [Abstract][Full Text] [Related]
48. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
[TBL] [Abstract][Full Text] [Related]
49. The role of lipid antigen presentation, cytokine balance, and major histocompatibility complex in a novel murine model of adoptive transfer of insulitis.
Ylinen L; Teros T; Liukas A; Arvilommi P; Sainio-Pöllänen S; Veräjänkorva E; Pöllänen P; Simell O
Pancreas; 2000 Mar; 20(2):197-205. PubMed ID: 10707937
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes.
Bai Y; Robinson E; Chai R; Ross JM; Reddy S
J Mol Histol; 2006 May; 37(3-4):101-13. PubMed ID: 17063385
[TBL] [Abstract][Full Text] [Related]
51. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
52. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
54. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
55. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
56. BB rat thymocytes cultured in the presence of islets lose their ability to transfer autoimmune diabetes.
Whalen BJ; Marounek J; Weiser P; Appel MC; Greiner DL; Mordes JP; Rossini AA
Diabetes; 2001 May; 50(5):972-9. PubMed ID: 11334440
[TBL] [Abstract][Full Text] [Related]
57. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
58. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process.
Corbett JA; Mikhael A; Shimizu J; Frederick K; Misko TP; McDaniel ML; Kanagawa O; Unanue ER
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8992-5. PubMed ID: 7692442
[TBL] [Abstract][Full Text] [Related]
59. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
Rothe H; O'Hara RM; Martin S; Kolb H
Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
[TBL] [Abstract][Full Text] [Related]
60. Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells.
Phillips JM; Harach SZ; Parish NM; Fehervari Z; Haskins K; Cooke A
J Immunol; 2000 Aug; 165(4):1949-55. PubMed ID: 10925277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
